Dr. Divya Tripathi

Dr. Divya Tripathi, Ph.D.

Specializing in Biomedical Engineering, Nanotechnology, and AI in Healthcare.

Profile Overview

Dr. Divya Tripathi holds a Ph.D. in Biomedical Engineering from the Indian Institute of Technology (IIT) Delhi. Her academic journey is driven by a passion for translational preclinical studies and bringing conceptual intelligence to state-of-the-art medical research facilities.


Her expertise spans Molecular Biology, Formulation Development, and Lab-on-a-chip technologies. Certified in small-animal imaging modalities (PET/SPECT), her pioneering work has been acknowledged globally, earning her the prestigious DST AWSAR Award and a research grant from Harvard Medical School, USA.

Professional Timeline

Present
Assistant Professor (SS)

Developing core curriculums in bio-instrumentation, biomedical engineering, bioimaging, and clinical monitoring.

2022
Postdoctoral Researcher - WHO-CDC (USA) / South Asian University

Researched and developed point-of-care testing (POCT) for Measles and Rubella Diagnosis.

2020 – 2022
Senior Research Fellow - INMAS, DRDO

Focused on advanced biomedical engineering and preclinical in-vivo modeling.

2018 – 2022
Ph.D. Biomedical Engineering - IIT Delhi

Advanced studies in translational preclinical models utilizing non-invasive gamma scintigraphy.

Selected Publications & Patents

Key Publications

  • Tailored MXenes and graphene as efficient telemedicine platforms for personalized health wellness. (K. R. Khondakar, D. Tripathi, et al.)
  • Therapeutic Techniques for Cancerous Tumor Cells and Future Aspects of Molecular Cancer Therapy. (D. Tripathi, K. S. Nayal - BJSTR 2023)
  • Multicancer Early Detection Tests for Cancer Diagnosis. (K. Hajra, D. Tripathi, D. Maity - JERP 2023)
  • Biomedical soft robotics in health care: Prospective, applications and challenges. (Book chapter: Elsevier)

Patents & Innovations

  • System for EEG Signal Categorization: Utilizing Long Short-Term Memory (LSTM) and Enhanced Methods of Neural Networks. (Application No: 202111052275)

Request Consultation

Open for academic collaborations, formulation development, and preclinical study designs.